EULAR recommendations for the management of antiphospholipid syndrome in adults

Cited by (1,254)

Items 401–500 of 1,254

1. Genetic Risk Score Improves Risk Stratification for Anticoagulation-Related Intracerebral Hemorrhage
   Ernst Mayerhofer, Livia Parodi, Savvina Prapiadou, Rainer Malik, Jonathan M. Rosand, Marios K. Georgakis, Christopher D. Anderson · 2023 · Stroke
2. The SPROUT study: A survey on current management practice of reproductive aspects in women of childbearing age with systemic autoimmune rheumatic diseases
   Cecilia Beatrice Chighizola, Megan E. B. Clowse, Pier Luigi Meroni, Laura Andréoli, Anǵela Tincani, Marianne Wallenius, Catherine Nelson‐Piercy · 2023 · Autoimmunity Reviews
3. Assessing disease activity and damage in antiphospholipid syndrome
   DANIELI CASTRO OLIVEIRA DE ANDRADE, Maria G. Tektonidou · 2023 · Clinical Immunology
4. How We Interpret Thrombosis with Thrombocytopenia Syndrome?
   Shinya Yamada, Hidesaku Asakura · 2024 · International Journal of Molecular Sciences
5. Reproductive Health in RA, Lupus, and APS
   Dina Zucchi, Chiara Tani, Marta Mosca · 2024 · JCR Journal of Clinical Rheumatology
6. Avascular Necrosis of the Femoral Head in Patients with Antiphospholipid Syndrome: A Case Series
   Paschalis Evangelidis, Eleni Gavriilaki, Nikolaos Kotsiou, Zacharo Ntova, Panagiotis Kalmoukos, Theodosia Papadopoulou, Sofia Chissan, Sofia Vakalopoulou · 2025 · Hematology Reports
7. Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives
   Rebecca DE LORENZO, Giuseppe Alvise Ramirez, Daniele Punzo · 2019 · Pharmacological Research
8. Diagnosis and treatment of patients with antiphospholipid syndrome: a mixed-method evaluation of care in The Netherlands
   Mirthe J Klein Haneveld, Caro H C Lemmen, Tammo E. Brunekreef et al. · 2020 · Rheumatology Advances in Practice
9. Artery of Percheron Infarct: A Rare Presentation of Acute Ischemic Stroke in a High-Risk Antiphospholipid Syndrome Patient
   Sreethish Sasi, Ashraf Ahmed, Wajiha Yousuf · 2020 · Case Reports in Acute Medicine
10. Direct Oral Anticoagulants in Select Patients With Hypercoagulable Disorders
    Sara M. Valanejad, Kyle Davis · 2020 · Annals of Pharmacotherapy
11. Current Status and Future Challenges in the Treatment of Rheumatic Diseases
    Enrique Roberto Soriano · 2022 · Frontiers in Drug Safety and Regulation
12. Evaluation of Apixaban in Patients With Antiphospholipid Syndrome: A Case Series and Review of Literature
    Khalid A. Al Sulaiman, Awatif M. Hafiz, Hisham A. Badreldin, Ghazwa B. Korayem, Faisal Alsuwayyid, Abdulrahman Alrashidi, Mohammed Alhijris, Faisal Falah Almutairi, Fahad Alharthi, Saad Ali Alghamdi et al. · 2022 · Journal of Investigative Medicine High Impact Case Reports
13. Antiphospholipid Syndrome in Patients with Venous Thromboembolism
    Vittorio Pengo, Gentian Denas · 2022 · Seminars in Thrombosis and Hemostasis
14. Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice
    Karen Ingrid Schreiber, Margreta Frishman, Mark Russell, Mrinalini Dey, Julia Flint, Alexander Allen, Amy Crossley, Mary Gayed, Kenneth K. Hodson, Munther A. Khamashta et al. · 2022 · Rheumatology
15. Venous Thromboembolism in the Inflammatory Rheumatic Diseases
    Durga Prasanna Misra, Sakir Ahmed, Mohit Goyal · 2022 · Rheumatic Disease Clinics of North America
16. Management of thromboembolic disorders during pregnancy in resource-constrained settings: An Indian perspective
    Pankaj Malhotra, Charanpreet Singh, Arihant Jain, Rimpy Tandon · 2023 · The Indian Journal of Medical Research
17. The ABCs of antiphospholipid syndrome
    Ayşe Bahar Keleşoğlu Dinçer, Doruk Erkan · 2023 · Archives of Rheumatology
18. New Insights into the Use of Direct Oral Anticoagulants in Non-high Risk Thrombotic APS Patients: Literature Review and Subgroup Analysis from a Meta-analysis
    Virginie Dufrost, Luc Darnige, Tatiana Magomedalievna Reshetnyak et al. · 2020 · Current Rheumatology Reports
19. “APS pregnancy – The offspring”
    Viktoria Bitsadze, Cecilia Nalli, Jamilya Kh. Khizroeva, Daniele Lini, Laura Andréoli, Andrea Lojacono, Elisa M. Fazzi, Yehuda Shoenfeld, Anǵela Tincani, Alexander Davidovich Makatsariya · 2020 · Lupus
20. Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers
    Ilenia Lorenza Calcaterra, Pasquale Ambrosino, Nicoletta Vitelli, Roberta Lupoli, Roberta Clara Orsini, Martina Chiurazzi, Mauro Maniscalco, Matteo Nicola Dario Di Minno · 2021 · Biomedicines
21. An advanced understanding of the heterogeneous clinical features of “non-criteria” obstetric antiphospholipid syndrome: Two case reports and a literature review
    Xue Peng, Xi Tan, Aiyun Xing · 2023 · Frontiers in Immunology
22. Profile and clinical relevance of non-criteria antiphospholipid antibodies in patients diagnosed with or highly suspected of APS
    Siting Li, Jiuliang Zhao, Yina Bai, Jingjing Meng, Qian Wang, Xinping Tian, Mengtao Li, Xiaofeng Zeng, Chaojun Hu · 2023 · Rheumatology
23. Criteria and non-criteria antiphospholipid autoantibodies screening in patients with late pregnancy morbidity: A cross-sectional study
    Clothilde Gros, Arthur Mageau, Tiphaine Barral, Pascale Nicaise‐Roland, Marie‐Hélène Saint‐Frison, Margot Bucau, Valérie Vivier, Valentine Marie Ferré, Agnès Bourgeois-Moine, T. Papo et al. · 2024 · Placenta
24. M2 macrophage derived exosomal miR-20a-5p ameliorates trophoblast pyroptosis and placental injuries in obstetric antiphospholipid syndrome via the TXNIP/NLRP3 axis
    Hongyuan Zhang, Ning Jiang, Mingyang Xu et al. · 2025 · Life Sciences
25. The Role of Hydroxychloroquine in the Management of Rheumatic Disorders: A Comprehensive Review
    İlker Ateş, Hilal Sahin, Lalu Muhammad Irham, Serkan Yılmaz, Halit Sinan Suzen · 2025 · Basic & Clinical Pharmacology & Toxicology
26. Activated Complement System’s Impact in Antiphospholipid Syndrome Thrombosis: From Pathophysiology to Treatment
    Sofia Tagara, Serena I. Valsami, Eleni Gavriilaki, Elias S. Kyriakou, Elisavet Grouzi, Paschalis Evangelidis, Paraskevi Karvouni, Georgia D. Kaiafa, Ioannis S. Papadakis, Aristarchos Poulis et al. · 2025 · Journal of Clinical Medicine
27. Antiphospholipid antibodies and atherosclerotic vascular disease: recent advances
    Anetta Undas, Jacek Musiał, Michał Ząbczyk · 2025 · Rheumatology International
28. Recurrence risk of venous thromboembolism associated with systemic lupus erythematosus: A retrospective cohort study
    Soerajja Bhoelan, Jaime Borjas Howard, Vladimir Tichelaar et al. · 2022 · Research and Practice in Thrombosis and Haemostasis
29. Role of autotaxin in systemic lupus erythematosus
    Yumi Tsuchida, Hirofumi Shoda, Tetsuji Sawada · 2023 · Frontiers in Medicine
30. Polish recommendations for diagnosis and therapy of paediatric stroke
    Ewa Pilarska, Ilona Kopyta, Edyta Szurowska · 2023 · Neurologia i Neurochirurgia Polska
31. Advances in Management of the Stroke Etiology One-Percenters
    Nicholas Dykman Osteraas, Rima M. Dafer · 2023 · Current Neurology and Neuroscience Reports
32. Direct oral anticoagulants vs. vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis
    Bidhan Bikram Shah, Abhirami Shankar, Vinesh Kumar et al. · 2023 · Annals of Medicine and Surgery
33. Adrenal Hemorrhage in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome: A Case Report and Literature Review
    Weiwei Jiang, Danrui Chen, Daizhi Yang, Longyi Zeng, Wen Xu, Shuo Lin · 2023 · International Journal of Endocrinology
34. Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)
    Cécile Yelnik, Zeynep Belce Erton, Élodie Drumez et al. · 2023 · Seminars in Arthritis and Rheumatism
35. Management of Rheumatic Diseases During Pregnancy and Breastfeeding
    Bettina Kuschel, Ute Margaretha Schäfer-Graf, M Schmidt · 2024 · Geburtshilfe und Frauenheilkunde
36. Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives
    Thomas Foret, Virginie Dufrost, Jérémy Lagrange · 2024 · Current Rheumatology Reports
37. Setting the bar differently: how to navigate old and new sets of criteria for the classification of antiphospholipid syndrome
    Anǵela Tincani, Laura Andréoli · 2024 · Lara D. Veeken
38. Predictors of damage accrual and its impact on health-related quality of life of thrombotic antiphospholipid syndrome: Independent validation of the damage index for antiphospholipid syndrome (DIAPS)
    Pedro Gaspar, Ana Sofia M Fernandes, A Abrantes, Inês Parreira, Inês Pires da Silva, Roberta Cristiane Torres da Silva, Mariana Nobre, Joana R Martins, Catarina Mota · 2024 · Lupus
39. 17β-Estradiol Promotes Proinflammatory and Procoagulatory Phenotype of Innate Immune Cells in the Presence of Antiphospholipid Antibodies
    Gayane P. Manukyan, Anush Martirosyan, Luděk Slavík, Jana Úlehlová, Martin Dihel, Tomáš Papajík, Eva Kriegová · 2020 · Biomedicines
40. Thrombophilia testing in patients with portal vein thrombosis
    Malene Helligsø Kirkeby, Julie Brogaard Larsen, Henning Grønbæk · 2020 · Scandinavian Journal of Clinical and Laboratory Investigation
41. Obstetric antiphospholipid syndrome
    Venina Isabel Poço Viana Leme de Barros, Ana Maria Kondo Igai, André Luiz Malavasi Longo de Oliveira, Marcelo Melzer Teruchkin, Fernanda Andrade Orsi · 2021 · Revista Brasileira Ginecologia e Obstetrícia
42. Systemic Lupus Erythematosus
    Bhavyata Parag, William Towers · 2017 · The American Pharmacists Association eBooks
43. Documento de consenso del Grupo de Estudio de Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN) para el diagnóstico y tratamiento de la nefritis lúpica
    Jorge Enrique Rojas-Rivera, Clara García-Carro, Ana I Ávila, Mar Espino, Mario Espinosa, Gema Maria Fernandez Juarez, Xavier Fulladosa, Marián Goicoechea, Manuel L. Macia, Enrique Morales et al. · 2022 · Nefrología
44. COVID-19 vaccine safety during pregnancy in women with systemic lupus erythematosus
    Nefeli Giannopoulou, Latika Gupta, Laura Andréoli · 2023 · Autoimmunity Reviews
45. Clinical phenotype, treatment strategy and pregnancy outcome of non‐criteria obstetric antiphospholipid syndrome
    Jiapo Li, Yue Hou, Liyang Zhang, Fan Li, Qian Liu, Yuanyuan Li, Hongfei Shen, Ziyue Xiong, Ling Huang, Chong Qiao · 2023 · American Journal of Reproductive Immunology
46. Lipid management in systemic lupus erythematosus according to risk classifiers suggested by the European Society of Cardiology and disease-related risk factors reported by the EULAR recommendations
    George C Drosos, George D. Konstantonis, Petros Paul Sfikakis, Maria G. Tektonidou · 2023 · RMD Open
47. Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature
    Ana Marco, Pascual Marco · 2023 · Seminars in Thrombosis and Hemostasis
48. High-throughput sequencing technology facilitates the discovery of novel biomarkers for antiphospholipid syndrome
    Qi Liu, Shuo Yang, Yuan Tan, Liyan Cui · 2023 · Frontiers in Immunology
49. Arterial thrombosis triggered by methotrexate-induced hyperhomocysteinemia in a systemic lupus erythematosus patient with antiphospholipid antibodies
    Chiara Schiavi, Luca Marri, Simone Matteo Negrini · 2023 · Thrombosis Journal
50. Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study
    Ariela Hoxha, Nicola Perin, Marco Lovisotto, Antonia Calligaro, Teresa Del Ross, Maria Favarò, Marta Tonello, Andrea Doria, Paolo Simioni · 2024 · Journal of Autoimmunity
51. T cell involvement in antiphospholipid syndrome
    Maria G. Tektonidou, Nikolaos I. Vlachogiannis, Petros Paul Sfikakis · 2024 · Clinical Immunology
52. Advances in the pharmacological management of systemic lupus erythematosus
    Alexander Tsoi, Dionysis Nikolopoulos, Ioannis Parodis · 2024 · Expert Opinion on Pharmacotherapy
53. Hydroxychloroquine and antiphospholipid antibody-related pregnancy morbidity: a systematic review and meta-analysis
    Margreta Frishman, Massimo Radin, Karen Ingrid Schreiber · 2020 · Current Opinion in Obstetrics & Gynecology
54. Thrombin generation in subjects with lupus anticoagulant without prior thrombosis or gestational morbidities
    Diego Velasco‐Rodríguez, Rosa Vidal Laso, Aránzazu García‐Raso, Ignacio Mahíllo, Karina Guzmán-López, Sara Martín‐Herrero, Elena Jiménez Barral, María C. Vegas-Sánchez, María José Martínez-Becerra, Reyes de la Plaza et al. · 2020 · Thrombosis Research
55. Efficacy of hydroxychloroquine in the prevention of thromboembolic events: A systematic review and meta-analysis
    Barros Edington, Fernando Luiz, de Rezende, Daniel Fraga, dos Santos, Luis Fernando Simões, Garcia, Rayssa Valandro, Gadelha, Sandra Rocha, Santiago, Mittermayer Barreto · 2022 · Lupus
56. Antiphospholipid syndrome and pregnancy
    Juan Fernando Romero Arauz, Angel García Alonso, Alma Lina Lara González, Patricia Rivera Velásquez, José Antonio Ayala Méndez · 2024 · Reumatizam
57. Deciphering Mechanisms, Prevention Strategies, Management Plans, Medications, and Research Techniques for Strokes in Systemic Lupus Erythematosus
    Ola A Al-Ewaidat, Moawiah M. Naffaa · 2024 · Medicines
58. Identification of common MicroRNAs expression signatures in antiphospholipid syndrome and thromboembolic disease: A scoping review
    Camila de Oliveira Vaz, Bruna Cardoso Jacintho, Gabrielle de Mello Santos, José Diogo Oliveira, Bruna de Moraes Mazetto, Murilo Vieira Geraldo, Fernanda Andrade Orsi · 2024 · Lupus
59. Pregnancy Outcomes in Women With Systemic Sclerosis Before and/or After Diagnosis and by Parity: A Swedish Population‐Based Cohort Study
    Weng Ian Che, Luigi Annicchiarico, Laura Andréoli · 2025 · Arthritis & Rheumatology
60. Complement in antiphospholipid syndrome, time to target?
    Marie‐Agnès Dragon‐Durey, Houcine Hamidi, Luc Darnige · 2025 · Current Opinion in Immunology
61. Systemic lupus erythematosus damage risk index (SLE-DRI): a simple machine learning-based tool for identifying patients at risk for early organ damage
    Panagiotis Garantziotis, Dionysis Nikolopoulos, Spyridon Katechis, Selahattin Alp Temiz, Danae-Mona Nöthling, Christina Adamichou, Christina Bergmann, Prodromos I. Sidiropoulos, Georg Andreas Schett, Antonis Fanouriakis et al. · 2025 · RMD Open
62. Immunopathogenesis of accelerated atherosclerosis in systemic lupus erythematosus: from innate and adaptive dysregulation to clinical implications
    Shirui Cao, Cheng Wang · 2026 · Frontiers in Immunology
63. Patients with Autoimmune Thyroid Diseases Have Higher Prevalence of Positive Antiphospholipid Antibodies: A Systematic Review and Meta-Analysis
    Difei Lu, Zhibo Song, Ying Gao, Junqing Zhang, Xiaohui Guo · 2022 · International Journal of Endocrinology
64. Severe thrombotic complications secondary to antiphospholipid syndrome and undiagnosed systemic lupus erythematosus
    Megan R.W. Barber, Ann Elaine Clarke, Corey D. Adams · 2022 · Canadian Medical Association Journal
65. Retrospective cohort study of thromboembolic events in systemic lupus erythematosus with or without secondary antiphospholipid syndrome and their correlation to lupus activity and dyslipidemia
    Ahmed Abdelatty Ibrahim, Hesham W. E. Shadi, Awab A. Y. Elamin, Hoda E. Draz · 2023 · Egyptian Rheumatology and Rehabilitation
66. Antiphospholipid Syndrome and Kidney Involvement
    Emanuele De Simone, Savino Sciascia, Roberta Fenoglio, Valentina Oddone, Antonella Barreca, Dario Roccatello · 2023 · Kidney & Blood Pressure Research
67. Portal vein thrombosis as extraintestinal complications of Crohn’s disease: a case report and review of literature
    Marouf Mouhammad Alhalabi, Duaa Nasri, Widad Aji · 2024 · Journal of Medical Case Reports
68. Interference of lupus anticoagulant causing antiprothrombin and anti–beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methods
    Rachel Gehlen, Roxanne G. Moesbergen, Cuicui Bai, Philip G. de Groot, A.J. Gerard Jansen, Joost C.M. Meijers, Bas de Laat, Jasper A. Remijn · 2024 · Research and Practice in Thrombosis and Haemostasis
69. Clinical Features Between Primary Obstetric Antiphospholipid Syndrome and Non‐Criteria Obstetric Antiphospholipid Syndrome and Risk Factors of Adverse Pregnancy Outcomes: A Retrospective Study of 1006 Cases
    Huimin Liu, Jinbiao Han, Rui Gao, Zhengyan Hu, Yuanting Tang, Lang Qin · 2024 · American Journal of Reproductive Immunology
70. Ubiquitin-proteasome system: a potential participant and therapeutic target in antiphospholipid syndrome
    He Wang, Yuan Tan, Qi Liu · 2025 · Frontiers in Immunology
71. Recent Advances in Chronic Thromboembolic Pulmonary Hypertension: Expanding the Disease Concept and Treatment Options
    Sung‐A Chang, Jeong Hoon Yang, Dong Seop Jeong · 2025 · Korean Circulation Journal
72. Statins as an Adjunctive Antithrombotic Agent in Thrombotic Antiphospholipid Syndrome: Mechanisms and Clinical Implications
    Tommaso Bucci, Danilo Menichelli, Ilaria Palumbo, Daniele Pastori, Paul R. J. Ames, Gregory Y.H. Lip, Pasquale Pignatelli · 2025 · Cells
73. Aspirin Desensitization: Implications for Acetylsalicylic Acid-Sensitive Pregnant Women
    Filipe Benito-Garcia, Inês Pires, Jorge José Albuquerque Vieira de Lima · 2021 · Medicina
74. Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. The multicenter ATHERO-APS study
    Tommaso Bucci, Paul R. J. Ames, Vittoria Cammisotto, Simona Bartimoccia, Massimo Triggiani, Roberta Parente, Antonio Ciampa, Pasquale Pignatelli, Roberto Carnevale, Daniele Pastori · 2022 · Journal of Autoimmunity
75. A Rare Case of Tricuspid Valve Libman–Sacks Endocarditis in a Pregnant Woman with Primary Antiphospholipid Syndrome
    Sonia Migliorini, Ciro Santoro, Alessandra Scatteia, Santo Dellegrottaglie, Antonella Tufano, Vittoria Cuomo, Emanuele Pilato, Giuseppe Comentale, Maria Rosaria D'Armiento, Maurizio Guida et al. · 2022 · Journal of Clinical Medicine
76. The adjusted Global Anti-Phospholipid Syndrome Score as predictor of damage accrual measured by Damage Index for APS: a longitudinal study
    Giuseppe Barilaro, Carlo Della Rocca, Alexandra Esteves, Ricard Cervera, Gerard Espinosa · 2022 · Rheumatology
77. Recurrent embolic strokes due to antiphospholipid syndrome and non-bacterial thrombotic endocarditis in a patient with basal cell carcinoma
    Julianna Svantner, Luc Lavanchy, Ania Labouchère · 2023 · Journal of Cardiothoracic Surgery
78. Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay
    Moore, Gary W., Foxton, Eleanor, Platton, Sean, Yartey, Nada, White, Danielle, MacDonald, Stephen G. · 2023 · Journal of Thrombosis and Haemostasis
79. Nécrose hémorragique bilatérale des surrénales sous apixaban : penser au syndrome des antiphospholipides ?
    Virginie Lavoipierre, M. Talbot, Caroline Soubrier et al. · 2019 · La Revue de Médecine Interne
80. The challenges and lessons learned in conducting clinical trials in pregnant women with antiphospholipid syndrome
    Leslie Skeith, Shannon M. Bates, Veronica Bates, Marc Alan Rodger · 2020 · Thrombosis Research
81. Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines
    Yinan Xiao, Hanyue Xu, Wen Qiang Guo, Yunuo Zhao, Yuling Luo, Ming Wang, Zhiyao He, Zhenyu Ding, Jiyan Liu, Lei Deng et al. · 2020 · Molecular Biomedicine
82. Neuropsychiatric Systemic Lupus Erythematosus: A Remaining Challenge
    Daniel Mrak, Michael Markus Bonelli, Helga Radner · 2022 · Current Pharmaceutical Design
83. Risk Factors and Outcomes of Acute Myocardial Infarction in a Cohort of Antiphospholipid Syndrome
    Yuzhou Gan, Yawei Zhao, Gongming Li, Hua Ye, Yunshan Zhou, Chang Jun Hou, Lan Wang, Jianping Guo, Chun Li · 2022 · Frontiers in Cardiovascular Medicine
84. Methylenetetrahydrofolate Reductase 677T Allele Is a Risk Factor for Arterial Thrombosis in Chinese Han Patients with Antiphospholipid Syndrome
    Zihan Tang, Hui Shi, Honglei Liu, Xiaobing Cheng, Yutong Su, Junna Ye, Yue Sun, Qiongyi Hu, Huihui Chi, Zhuochao Zhou et al. · 2022 · Biomedicines
85. Dilemmas in hematology: consults in patients with arterial thrombosis
    Dawn Swan, Jean M. Connors, Jecko V. Thachil · 2023 · Journal of Thrombosis and Haemostasis
86. Hot Topic: Direkte orale Antikoagulanzien (DOACs) beim Antiphospholipidsyndrom?
    Christof Specker, Thomas Dörner, Matthias Schneider · 2019 · Zeitschrift für Rheumatologie
87. The Antiphospholipid Syndrome
    David P. D’Cruz, Jason S. Knight, Lisa R. Sammaritano, Jane E. Salmon, Ricard Cervera, Munther A. Khamashta · 2023 · Springer eBooks
88. Thrombotic risk in antiphospholipidic syndrome: From hypothesis to current evidence (Review)
    Claudia Mihaela Gavris, Laurențiu Dănuț Nedelcu, Alina Mihaela Pascu · 2021 · Experimental and Therapeutic Medicine
89. Successful pregnancies in a patient with Takayasu arteritis and antiphospholipid syndrome, maintained on infliximab corticosteroid-free regimen: case-based review
    Žikica Jovičić, Sanja Dragašević, Ana Petković · 2023 · Rheumatology International
90. The characteristics and risk factors of cerebrovascular events in young systemic lupus erythematosus patients: A case-control study
    Uei-Hsiang Hsu, Yu‐Tsan Lin, Bor‐Luen Chiang · 2023 · Journal of the Formosan Medical Association
91. Non-Criteria Obstetric Antiphospholipid Syndrome: Myth or Reality?
    Sara Beça, Maria Borrell, Ricard Cervera, F. Figueras, Alfons Nadal, Gerard Espinosa, Núria Baños · 2025 · Journal of Clinical Medicine
92. Risk factors for bleeding in patients with thrombotic antiphospholipid syndrome during antithrombotic therapy
    Pedro Gaspar, Prabal Mittal, Hannah Cohen · 2025 · Lupus
93. Thrombin generation test as a useful tool for improving disease severity stratification in antiphospholipid syndrome
    Cécile Yelnik, Anne Bauters, Julien Labreuche, Maximilien Desvages, David Launay, Eric HACHULLA, Sylvain Dubucquoi, Steve Lancel, Marie Frimat, M. Lambert · 2025 · RMD Open
94. Evaluating the Efficacy and Safety of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Antiphospholipid Syndrome: Updated Systematic Review and Meta-Analysis
    Lama Alfehaid, Nada Alsuhebany, Hussah N Albahlal, Albatoul Alomran, Abdulmajeed M. Alshehri, Mohammed Abdullah Alsheef, Abdulaali R. Almutairi · 2025 · Clinical and Applied Thrombosis/Hemostasis
95. S2k-Leitlinie „Diagnostik und Therapie der systemischen Sklerose“
    Jörg Henes, Swantje Arndt, Melanie Patricia Berger, Michael Czihal, Jörg H. W. Distler, Christian Erbel, Thomas Frieling, Claudia Günther, Isabell Haase, Nicolas Hunzelmann et al. · 2025 · Zeitschrift für Rheumatologie
96. CD40-CD40L inhibition attenuates platelet-neutrophil interaction and neutrophil extracellular trap release in primary antiphospholipid syndrome
    Stavros Naoum, Charilaos Spyropoulos, Andriani Angelopoulou, Harikleia Gakiopoulou, Michalis Katsimpoulas, Vassilis G. Gorgoulis, Petros Paul Sfikakis, Konstantinos Ritis, Ioanna E. Galani, Konstantinos Kambas et al. · 2026 · Annals of the Rheumatic Diseases
97. Primary antiphospholipid syndrome revealed by acute myocardial infarction in young adults: a prospective observational study
    Julie Chezel, Quentin Fischer, Pascale Nicaise Roland · 2020 · Thrombosis Research
98. The Safety of Medications During Pregnancy and Lactation in Patients with Inflammatory Rheumatic Diseases
    Ji-Won Kim, Chang‐Hee Suh · 2021 · European Medical Journal
99. The Antiphospholipid Syndrome in the Pediatric Population
    Elizabeth E. Sloan, Deborah McCurdy · 2022 · Advances in Pediatrics
100. Viewpoint: Lupus anticoagulant detection and interpretation in antiphospholipid syndrome
     Efthymiou, Maria, Bertolaccini, Maria Laura, Cohen, Hannah · 2024 · Rheumatology